OGEN - Oragenics +13% on advancement of COVID-19 program July, 10 2020 07:51 AM Oragenics Inc. Oragenics (NYSEMKT:OGEN) is up 13% premarket on the heels of an update on its SARS-CoV-2 vaccine candidate TerraCoV2.More news on: Oragenics, Inc., Healthcare stocks news, Stocks on the move, Read more ...